Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Jay H. Hoofnagle et al.|New England Journal of Medicine|2010Cited by 3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Endpoints and clinical trial design for nonalcoholic steatohepatitisArun J. Sanyal, Arthur J. McCullough, Elizabeth M. Brunt et al.|Hepatology|2011Cited by 757
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose TissueRebecca C. Schugar, J. Mark Brown, Diana M. Shih et al.|Cell Reports|2017Cited by 290
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050Phuc Le, Michael B. Rothberg, Moosa Tatar et al.|JAMA Network Open|2025Cited by 177